Pulmatrix to Divest 146-Patent Inhalation Technology Portfolio as Cullgen Merger Advances
- Posted on August 6, 2025
- By Google News
- 1 Views
Pulmatrix to Divest 146-Patent Inhalation Technology Portfolio as Cullgen Merger Advances
Pulmatrix seeks buyers for iSPERSE™ inhalation technology with 146 patents amid strategic merger with Cullgen. Q2 results and merger timeline revealed. Learn more.
